| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 08/01/2013 | US20130196342 Compositions And Methods For Modulating S-Nitrosogluthione Reductase |
| 08/01/2013 | US20130195992 Amniotic membrane preparations and purified compositions and anti-angiogenesis treatment |
| 08/01/2013 | US20130195990 Composition of whey growth factor extract for reducing muscle inflammation |
| 08/01/2013 | US20130195985 Composition Comprising SOD, Lutein and Zeaxanthin |
| 08/01/2013 | US20130195959 Lyophilized platelet lysates |
| 08/01/2013 | US20130195940 Method to inhibit recruitment of monocytes and macrophages by an icam-3 inhibitor |
| 08/01/2013 | US20130195939 Methods and compositions for oral administration of exenatide |
| 08/01/2013 | US20130195926 Modulation of nitric oxide signaling to normalize tumor vasculature |
| 08/01/2013 | US20130195895 Methods of modulating immune responses by modulating tim-1, tim-2 and tim-4 function |
| 08/01/2013 | US20130195893 Use of a pneumococcal p4 peptide for enhancing opsonophagocytosis in response to a pathogen |
| 08/01/2013 | US20130195887 Pharmacological vitreolysis |
| 08/01/2013 | US20130195886 Methods for Fructanase and Fructokinase Inhibition |
| 08/01/2013 | US20130195885 Compositions with Hematopoietic and Immune Activity |
| 08/01/2013 | US20130195884 Novel modulators of trail signalling |
| 08/01/2013 | US20130195874 Anti-adrenomedullin (adm) antibody or anti-adm antibody fragment or anti-adm non-ig scaffold for reducing the risk of mortality in a patient having a chronic or acute disease or acute condition |
| 08/01/2013 | US20130195868 Treating surface of the eye disorders |
| 08/01/2013 | US20130195866 Methods to inhibit neurodegeneration |
| 08/01/2013 | US20130195863 Methods and Pharmaceutical Compositions for the Treatment of Bone Density Related Diseases |
| 08/01/2013 | US20130195859 Compositions and methods for modulating cardiac conditions |
| 08/01/2013 | US20130195856 Methods of altering bone growth by administration of sost or wise antagonist or agonist |
| 08/01/2013 | US20130195838 Methods of Treating Cancer Using Growth Factor Retargeted Endopeptidases |
| 08/01/2013 | US20130195837 Methods for the prevention or treatment of vessel occlusion injury |
| 08/01/2013 | US20130195834 Treatment of glycogen storage disease type ii |
| 08/01/2013 | US20130195833 Methods and compositions for the treatment of symptoms of prion diseases |
| 08/01/2013 | US20130195831 Silk-based drug delivery system |
| 08/01/2013 | US20130195830 Perorally applicable preparation containing histaminase of vegetable origin, resistant to pepsin and trypsin and a process for producing it |
| 08/01/2013 | US20130195828 Pharmaceutical Compositions and Methods for Digesting Atherosclerotic Plaques |
| 08/01/2013 | US20130195817 Methods and compositions for modulating angiogenesis and vasculogenesis |
| 08/01/2013 | US20130195807 Agonists of growth hormone releasing hormone as effectors for survival and proliferation of pancreatic islets |
| 08/01/2013 | US20130195805 Modification of reactivity of bone constructs |
| 08/01/2013 | US20130195801 Cns targeting aav vectors and methods of use thereof |
| 08/01/2013 | US20130195800 Vectors Conditionally Expressing Therapeutic Proteins, Host Cells Comprising the Vectors, and Uses Thereof |
| 08/01/2013 | US20130195798 Combination therapy for treatment of viral infections |
| 08/01/2013 | US20130195797 High potency formulations of vx-950 |
| 08/01/2013 | US20130195771 Gantrez Hydrogel With Dry Tack |
| 08/01/2013 | US20130195770 Composition and method for reducing atherosclerotic lesions |
| 08/01/2013 | US20130195769 Oleaginous pharmaceutical and cosmetic foam |
| 08/01/2013 | US20130195765 Method for treating and diagnosing cancer by using cell-derived microvesicles |
| 08/01/2013 | US20130195764 Nanoparticle Targeting to Ischemia for Imaging and Therapy |
| 08/01/2013 | US20130195751 Self-assembed conjugate and use thereof |
| 08/01/2013 | CA2862485A1 Peptide agents for cancer therapy |
| 08/01/2013 | CA2861392A1 Peptide antagonists of the calcitonin cgrp family of peptide hormones and their use |
| 07/31/2013 | EP2620445A1 Polypeptide tf1 for inhibiting type 2 shiga toxin activity, encoding gene for same and use thereof |
| 07/31/2013 | EP2620156A2 Pharmaceutical composition for preventing or treating immune diseases or inflammatory diseases, containing stem cells treated with nod2 agonist or cultured product thereof |
| 07/31/2013 | EP2619592A1 Biomarkers associated with pre-diabetes, diabetes and diabetes related conditions |
| 07/31/2013 | EP2619229A2 Multimeric il-15 soluble fusion molecules and methods of making and using same |
| 07/31/2013 | EP2618842A1 Novel immunostimulatory method |
| 07/31/2013 | EP2618832A2 Composition comprising sod, lutein and zeaxanthin |
| 07/31/2013 | EP2618831A1 Macrocyclic proline derived hcv serine protease inhibitors |
| 07/31/2013 | EP2618830A1 Formulations for bovine granulocyte colony stimulating factor and variants thereof |
| 07/31/2013 | EP2618829A2 Therapeutic applications of smad7 |
| 07/31/2013 | EP2618668A1 Mosquitocidal xenorhabdus, lipopeptide and methods |
| 07/31/2013 | CN103228290A Composition containing inducer of sirt1 expression for preventing or treating sepsis or septic shock |
| 07/31/2013 | CN103228289A Treating non-hematopoietic cancer with interleukin 6 |
| 07/31/2013 | CN103228288A Hla-g isoform for use in the treatment of a disease associated with bone resorption |
| 07/31/2013 | CN103228265A Liquid formulations of long acting interferon alpha conjugate |
| 07/31/2013 | CN103228160A Antimicrobial protein |
| 07/31/2013 | CN103224957A Method for producing red blood cell drug containing L-ASPase II by in vitro induction |
| 07/31/2013 | CN103224940A Blunt snout bream beta-defensin gene and protein encoded by the same |
| 07/31/2013 | CN103224907A Perivascular mesenchymal precursor cells |
| 07/31/2013 | CN103224898A Marine bacillus and its polypeptide with antitumor activity |
| 07/31/2013 | CN103224562A Epitope regions of a thyrotrophin (TSH) receptor, and antibodies thereto |
| 07/31/2013 | CN103224557A Development of long-acting fibroblast growth factor-23 antagonist |
| 07/31/2013 | CN103224556A Huntingdon disease (HD)-targeted proteins and their coding genes and use |
| 07/31/2013 | CN103224549A Schizophyllum commune antiviral protein, and preparation method and application thereof |
| 07/31/2013 | CN103224545A Sulfur-containing compound with nerve protection effect and application thereof |
| 07/31/2013 | CN103223161A Application of manganese superoxide dismutase stimulant in preparing liver-protecting drug |
| 07/31/2013 | CN103223160A Cation complexes of insulin compund conjugates, formulation and uses thereof |
| 07/31/2013 | CN103223159A Application of enteric maramins androsaceus glycoprotein microspheres comprising absorption enhancer in preparing pain-relieving and anti-inflammatory medicines |
| 07/31/2013 | CN103222963A 生长抑素冻干粉针剂 Somatostatin freeze-dried powder |
| 07/31/2013 | CN103222959A Interleukin-2 long-acting slow-release microsphere, preparation method and application thereof |
| 07/31/2013 | CN102816770B Cotesia plutellae antimicrobial peptide defensin gene, antimicrobial peptide and application |
| 07/31/2013 | CN102703489B Construction method for prokaryotic secretory expression vector of protein transduction domain-Apoptin (PTD-Apoptin) fusion protein and application of prokaryotic secretory expression vector |
| 07/31/2013 | CN102676490B Lywallzyme of phage of staphylococcus aureus as well as preparation method and application thereof |
| 07/31/2013 | CN102659926B Pc-E polypeptide inhibiting aspergillus fumigatus from adhering to cornea |
| 07/31/2013 | CN102617738B Polypeptides, coding sequences, preparation method and use of recombinant fusion protein CLD |
| 07/31/2013 | CN102584949B Pc-C polypeptide inhibiting aspergillus fumigatus from adhering to cornea |
| 07/31/2013 | CN102558360B Trypsin inhibitor and preparation method and application thereof |
| 07/31/2013 | CN102524558B Feed additive for treating dairy cattle recessive mastitis |
| 07/31/2013 | CN102321178B Novel gonadotropin releasing hormone oriented fusion protein mutant |
| 07/31/2013 | CN102295695B Recombinant human follicle stimulating hormone and preparation thereof |
| 07/31/2013 | CN102271713B Neurotensin-derived branched peptides and uses thereof |
| 07/31/2013 | CN102206660B Engineered protein TAT-VP28 against white spot syndrome virus of shrimp and its preparation and purpose |
| 07/31/2013 | CN102174095B Malania oleifera lectin and method for preparing same |
| 07/31/2013 | CN102078602B Antitumor composite and preparation method thereof |
| 07/31/2013 | CN102046193B Compositions and methods for using cells to treat heart tissue |
| 07/31/2013 | CN101906455B Preparation method of egg white protein assistant antihypertensive peptides |
| 07/31/2013 | CN101679498B Bis-met histones |
| 07/31/2013 | CN101663045B A composition containing arazyme for the prevention and treatment of cancer |
| 07/31/2013 | CN101294187B Method for sustained-releasing polypeptide with biological activity and application thereof |
| 07/31/2013 | CN101117635B Fusion expression of PTD,HIF ODD and tumour inhibitory gene and uses thereof |
| 07/30/2013 | US8497398 Polyamine transporter selective compounds as anti-cancer agents |
| 07/30/2013 | US8497357 Degradable heterobifunctional poly(ethylene glycol) acrylates and gels and conjugates derived therefrom |
| 07/30/2013 | US8497353 Polypeptides for microbial detection |
| 07/30/2013 | US8497352 Use of Wnt5-α peptide derivates for the treatment of melanoma and gastric cancer |
| 07/30/2013 | US8497351 Nucleic acid and corresponding protein entitled 162P1E6 useful in treatment and detection of cancer |
| 07/30/2013 | US8497349 Use of multivalent synthetic ligands of surface nucleolin for treating cancer or inflammation |
| 07/30/2013 | US8497348 Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
| 07/30/2013 | US8497347 Methods of treating medical conditions using peptides |
| 07/30/2013 | US8497275 HCV protease inhibitors and uses thereof |